Corcept Therapeutics Incorporated Stock Price on February 4, 2022
| CORT Stock | USD 22.48 0.52 2.26% |
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Corcept Therapeutics stands at 22.48, as last reported on the 25th of April, with the highest price reaching 23.29 and the lowest price hitting 22.05 during the day. We consider Corcept Therapeutics very steady. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0352, which signifies that the company had a 0.0352% return per unit of risk over the last 3 months. We have found thirty technical indicators for Corcept Therapeutics Incorporated, which you can use to evaluate the volatility of the firm. Please confirm Corcept Therapeutics' Downside Deviation of 2.82, mean deviation of 2.12, and Risk Adjusted Performance of 0.0296 to double-check if the risk estimate we provide is consistent with the expected return of 0.0952%.
Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Corcept |
Sharpe Ratio = 0.0352
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CORT | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Corcept Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corcept Therapeutics by adding it to a well-diversified portfolio.
Corcept Therapeutics Valuation on February 4, 2022
It is possible to determine the worth of Corcept Therapeutics on a given historical date. On February 4, 2022 Corcept was worth 24.86 at the beginning of the trading date compared to the closed value of 24.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corcept Therapeutics stock. Still, in general, we apply an absolute valuation method to find Corcept Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corcept Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corcept Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/11/2022 | 24.86 | 24.86 | 24.02 | 24.06 | 773,300 |
| 24.05 | 24.59 | 24.04 | 24.24 | 760,500 |
| Backtest Corcept Therapeutics | | | Corcept Therapeutics History | | | Corcept Therapeutics Valuation | Next |
Corcept Therapeutics Trading Date Momentum on February 4, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Corcept Therapeutics Fundamentals Correlations and Trends
By evaluating Corcept Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corcept financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Corcept Therapeutics Stock history
Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California. Corcept Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 238 people.
Corcept Therapeutics Stock Technical Analysis
Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Corcept Therapeutics Period Price Range
Low | April 11, 2022
| High |
24.86 | 24.06 |
Corcept Therapeutics April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Corcept Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corcept Therapeutics shares will generate the highest return on investment. By undertsting and applying Corcept Therapeutics stock market strength indicators, traders can identify Corcept Therapeutics Incorporated entry and exit signals to maximize returns
| Accumulation Distribution | 26129.2 | |||
| Daily Balance Of Power | (0.95) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 24.44 | |||
| Day Typical Price | 24.31 | |||
| Price Action Indicator | (0.78) | |||
| Period Momentum Indicator | (1.58) | |||
| Relative Strength Index | 70.91 |
Corcept Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0296 | |||
| Jensen Alpha | 0.1434 | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0026 | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Corcept Stock analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.